Daiichi Sankyo: Clinical Trials & FDA Approval Profile
Daiichi Sankyo (Tokyo, JP / Basking Ridge, NJ) sponsors 60 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 39 active protocols (20 recruiting now), 17 completed protocols, and 6 all-time original FDA Drugs@FDA NDA and BLA approvals.